RNU1-30P

Across TCGA pan-cancer cohorts, RNU1-30P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU1-30P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU1-30P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-30P expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

THCA, SKCM, and UCEC are the cancer types where RNU1-30P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.507	0.947	<.001	138	view →
SKCM	DFS	Tertile	II,III,IV	0.040	0.683	<.001	81	view →
UCEC	DFS	Tertile	All	0.595	0.846	<.001	72	view →
CHOL	DFS	Tertile	All	0.066	0.519	.013	54	view →
READ	DFS	Tertile	All	0.255	0.844	.004	54	view →
LGG	DFS	Tertile	All	0.605	0.752	.012	24	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
UCS	OS	Tertile	All	0.185	0.686	.034	18	view →
THYM	OS	Tertile	All	0.381	0.878	.017	12	view →
LUSC	OS	Tertile	All	0.910	0.763	.019	12	view →
MESO	OS	Tertile	II,III,IV	0.203	0.576	.043	9	view →
ACC	OS	Tertile	III,IV	0.273	0.786	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU1-30P–THCA (OS)

Open the THCA breakdown →